Antimalarial Agents Targeting Plasmodium falciparum Carbonic Anhydrase: Towards Artesunate Hybrid Compounds with Dual Mechanism of Action.


Journal

ChemMedChem
ISSN: 1860-7187
Titre abrégé: ChemMedChem
Pays: Germany
ID NLM: 101259013

Informations de publication

Date de publication:
02 Nov 2023
Historique:
revised: 07 09 2023
received: 15 05 2023
medline: 10 11 2023
pubmed: 12 9 2023
entrez: 12 9 2023
Statut: ppublish

Résumé

Malaria continues to be a major public health challenge worldwide and, as part of the global effort toward malaria eradication, plasmodium carbonic anhydrases (CAs) have recently been proposed as potential targets for malaria treatment. In this study, a series of eight hybrid compounds combining the Artesunate core with a sulfonamide moiety were synthesized and evaluated for their inhibition potency against the widely expressed human (h) CAs I, II and the isoform from P. falciparum (PfCA). All derivatives demonstrated high inhibition potency against PfCA, achieving a K

Identifiants

pubmed: 37697903
doi: 10.1002/cmdc.202300267
doi:

Substances chimiques

Antimalarials 0
Artesunate 60W3249T9M
Carbonic Anhydrases EC 4.2.1.1
Carbonic Anhydrase Inhibitors 0
Protein Isoforms 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e202300267

Subventions

Organisme : Ministero dell'Università e della Ricerca
ID : FISR_04819

Informations de copyright

© 2023 Wiley-VCH GmbH.

Références

T. E. Fletcher, N. J. Beeching, J. R. Army Med. Corps 2013, 159, 158-166.
http://www.who.int/publications/i/item/9789240064898 (accessed on 14/05/2023).
J. Park, S. Kang, D. Seok, Y. J. Baek, S. Y. An, J. Lee, A. Jun, S. Y. Kim, Malar. J. 2023, 22, 41.
D. J. Weiss, A. Bertozzi-Villa, S. F. Rumisha, P. Amratia, R. Arambepola, K. E. Battle, E. Cameron, E. Chestnutt, H. S. Gibson, J. Harris, S. Keddie, J. J. Millar, J. Rozier, T. L. Symons, C. Vargas-Ruiz, S. I. Hay, D. L. Smith, P. L. Alonso, A. M. Noor, S. Bhatt, P. W. Gething, Lancet Infect. Dis. 2021, 21, 59-69.
http://www.who.int/publications/i/item/9789240031357 (accessed on 14/05/2023).
B. Hanboonkunupakarn, J. Tarning, S. Pukrittayakamee, K. Chotivanich, Front. Pharmacol. 2022, 13, 876282.
K. E. Ward, D. A. Fidock, J. L. Bridgford, Curr. Opin. Microbiol. 2022, 69, 102193.
G. H. Posner, C. H. Ho, J. Am. Chem. Soc. 1992, 114, 8328-8329.
U. Eckstein-Ludwig, R. J. Webb, I. D. Van Goethem, J. M. East, A. G. Lee, M. Kimura, P. M. O′Neill, P. G. Bray, S. A. Ward, S. Krishna, Nature. 2003, 424, 957-961.
T. Efferth, Drug Resist. Updates 2005, 8, 85-97.
C. Aurrecoechea, J. Brestelli, B. P. Brunk, J. Dommer, S. Fischer, B. Gajria, X. Gao, A. Gingle, G. Grant, O. S. Harb, M. Heiges, F. Innamorato, J. Iodice, J. C. Kissinger, E. Kraemer, W. Li, J. A. Miller, V. Nayak, C. Pennington, D. F. Pinney, D. S. Roos, C. Ross, C. J. Stoeckert Jr, C. Treatman, H. Wang, Nucleic Acids Res. 2009, 37, D539-D543.
UniProt Consortium. Nucleic Acids Res. 2023, 51, D523-D531.
C. T. Supuran, Clin. Sci. 2021, 135, 1233-1249.
C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2016, 31, 345-360.
C. T. Supuran, Biochem. J. 2016, 473, 2023-2032.
S. Del Prete, V. De Luca, G. De Simone, C. T. Supuran, C. Capasso, J. Enzyme Inhib. Med. Chem. 2016, 31, 54-59.
S. Del Prete, D. Vullo, G. M. Fisher, K. T. Andrews, S. A. Poulsen, C. Capasso, C. T. Supuran, Bioorg. Med. Chem. Lett. 2014, 24, 4389-4396.
K. K. Sein, M. Aikawa, Med. Hypotheses 1998, 50, 19-23.
C. T. Supuran, C. Capasso, Expert Opin. Ther. Targets 2015, 19, 551-63.
C. Zimmerman, J. W. Babich, J. Joyal, G. Lu, K. P. Maresca, C. Barone, Inhibitors of Carbonic Anhydrase IX, 2009, US2009175794A1.
M. Ali, M. Bozdag, U. Farooq, A. Angeli, F. Carta, P. Berto, G. Zanotti, C. T. Supuran, Int. J. Mol. Sci. 2020, 21, 2560.
J. Häfliger, O. O. Sokolova, M. Lenz, C. G. Daniliuc, R. Gilmour, Angew. Chem. Int. Ed. Engl. 2022, 61, e202205277.
A. Angeli, L. Micheli, F. Carta, M. Ferraroni, T. Pirali, A. Fernandez Carvajal, A. Ferrer Montiel, L. Di Cesare Mannelli, C. Ghelardini, C. T. Supuran, J. Med. Chem. 2023, 66, 1616-1633.
R. G. Khalifah, J. Biol. Chem. 1971, 246, 2561-2573.
D. Lagorce, O. Sperandio, H. Galons, M. A. Miteva, B. O. Villoutreix, BMC Bioinf. 2008, 9, 396.
A. Daina, O. Michielin, V. Zoete, Sci. Rep. 2017, 7, 42717.
J. B. Baell, G. A. Holloway, J. Med. Chem. 2010, 53, 2719-2740.
S. Galati, M. Di Stefano, E. Martinelli, M. Macchia, A. Martinelli, G. Poli, T. Tuccinardi, Int. J. Mol. Sci. 2022, 23, 2105.
D. Vullo, L. Syrjänen, M. Kuuslahti, S. Parkkila, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2018, 33 (1), 359-363.
L. Syrjänen, M. Kuuslahti, M. Tolvanen, D. Vullo, S. Parkkila, C. T. Supuran, Bioorg. Med. Chem. 2015, 23 (10), 2303-2309.
P. J. Linser, K. E. Smith, T. J. Seron, M. Neira Oviedo, J. Exp. Biol. 2009, 212 (11), 1662-1671.
C. T. Supuran, Nat. Rev. Drug Discovery 2008, 7, 168-181.
A. Angeli, S. Del Prete, F. A. S. Alasmary, L. S. Alqahtani, Z. AlOthman, W. A. Donald, C. Capasso, C. T. Supuran, Bioorg. Chem. 2018, 80, 94-98.
İ. Gülçin, A. Scozzafava, C. T. Supuran, H. Akıncıoğlu, Z. Koksal, F. Turkan, S. Alwasel, J. Enzyme Inhib. Med. Chem. 2016, 31 (6), 1095-1101.
A. Mocan, S. Carradori, M. Locatelli, D. Secci, S. Cesa, A. Mollica, S. Riga, A. Angeli, C. T. Supuran, C. Celia, L. Di Marzio, Food Chem. Toxicol. 2018, 112, 441-447.
A. Angeli, M. Pinteala, S. S. Maier, S. Del Prete, C. Capasso, B. C. Simionescu, C. T. Supuran, J. Enzyme Inhib. Med. Chem. 2019, 34, 644-650.
C. H. Kocken, H. Ozwara, A. van der Wel, A. L. Beetsma, J. M. Mwenda, A. W. Thomas, Infect. Immun. 2002, 70, 655-660.
W. Trager, J. B. Jensen, Science. 1976, 193, 673-675.
R. Piper, J. Lebras, L. Wentworth, A. Hunt-Cooke, S. Houzé, P. Chiodini, M. Makler, Am. J. Trop. Med. Hyg. 1999, 60, 109-118.
S. Manzoor, A. Angeli, S. Zara, S. Carradori, M. A. Rahman, M. K. Raza, C. T. Supuran, N. Hoda, Eur. J. Med. Chem. 2022, 243, 114793.
R. F. A. Azeez, S. Zara, A. Ricci, S. Dev, A. Vengamthodi, F. S. Kavully, R. A. Abdu, K. T. Kalathil, M. A. Abdelgawad, B. Mathew, S. Carradori, Res. Chem. Intermed. 2023, 49, 203-220.
A. Ricci, M. Gallorini, D. Del Bufalo, A. Cataldi, I. D′Agostino, S. Carradori, S. Zara, Molecules. 2022, 27 (3), 957.
M. A. Alagöz, Z. Özdemir, M. Uysal, S. Carradori, M. Gallorini, A. Ricci, S. Zara, B. Mathew, Pharmaceuticals. 2021, 14 (3), 183.
S. F. Altschul, W. Gish, W. Miller, E. W. Myers, D. J. Lipman, J. Mol. Biol. 1990, 215, 403-410.

Auteurs

Ilaria D'Agostino (I)

Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy.

Susi Zara (S)

Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy.

Simone Carradori (S)

Department of Pharmacy "G. d'Annunzio", University of Chieti-Pescara, 66100, Chieti, Italy.

Viviana De Luca (V)

Istituto di Bioscienze e Biorisorse CNR, 80131, Napoli, Italy.

Clemente Capasso (C)

Istituto di Bioscienze e Biorisorse CNR, 80131, Napoli, Italy.

Clemens H M Kocken (CHM)

Department of Parasitology, Biomedical Primate Research Center, 2288, Rijswijk, The Netherlands.

Anne-Marie Zeeman (AM)

Department of Parasitology, Biomedical Primate Research Center, 2288, Rijswijk, The Netherlands.

Andrea Angeli (A)

Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy.

Fabrizio Carta (F)

Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy.

Claudiu T Supuran (CT)

Neurofarba Department, University of Florence, 50019, Sesto Fiorentino FL, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH